Purchase Order 75N95019P00563
Award Date
8/23/19
Potential Completion Date
9/25/20
Potential Value
$8K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
A&G Pharmaceutical, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $14,630.25 contract is for the development of monoclonal antibodies to support biomedical research. Precision Antibody has provided similar services to HHS components like the National Cancer Institute and Department of...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...
The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...
This $13,670 federal contract was awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of custom antibodies and related products for biomedical research. The contract was issued as a purchase order for the delivery of custom antibodies. Precision Antibody has a strong track record of federal contract awards, primarily from NIH institutes, for providing specialized biological materials and services to...
The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a $18,500 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for laboratory testing, fusion, and cloning services. The contract has an ultimate completion date of November 30, 2024 and does not have a set-aside designation. This award is part of a larger $100 million Blanket Purchase Agreement (BPA)...
The federal contract award HHSN272201400119P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the prime contractor A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $30,264.00 firm-fixed-price purchase order is for the production of 1 mg of precision antibodies. This contract is not associated with a set-aside program. A&G Pharmaceutical, Inc. is a for-profit manufacturer of goods that...
This is a firm-fixed price delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $107,461.88 contract is for the delivery of polyclonal rat antibodies and monoclonal rat antibodies against glycol-chitosan nanoparticles. This award is part of a larger $100 million single-award...
This federal contract was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for a COVID-19-related project analyzing a novel truncated form of the ACE2 receptor. The $19,349.65 firm-fixed-price purchase order was awarded on June 18, 2020, with a period of performance through June 19, 2020. The contract was awarded without any set-aside designation, indicating open competition....